Sedative drug may improve visibility in sinus surgery

NCT ID NCT06866145

Completed Symptom relief Sponsor: Menoufia University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether adding the sedative drug dexmedetomidine to anesthesia improves the view for surgeons during endoscopic sinus surgery. Fifty adults with rhinosinusitis were enrolled. The goal was to see if the drug could make the surgical field clearer, potentially making the procedure safer and more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexmedetomidine (a sedative drug)
What this could lead to: If successful, this could help surgeons see better during sinus surgery, potentially leading to safer and more effective procedures.
What could go wrong: This is a small, completed Phase 4 trial with only 50 participants. Results may not apply to all patients, and the drug may cause side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic rhinosinusitis Rhinosinusitis sinusitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHINOSINUSITIS

Contacts and locations

Locations

Menoufia university hospital

Menoufia, Shibin Elkom, 6121890, Egypt
Menoufia university hospital

Shibin Elkom, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.